Literature DB >> 25078693

Combined effects of the structural heterogeneity and dynamics of flaviviruses on antibody recognition.

Kimberly A Dowd1, Swati Mukherjee1, Richard J Kuhn2, Theodore C Pierson3.   

Abstract

Flaviviruses are thought to sample an ensemble of structures at equilibrium. One consequence of a structurally dynamic virion is the observed time-dependent increases in neutralization sensitivity that can occur after prolonged incubation with antibody. Differences in how virus strains "breathe" may affect epitope exposure and contribute to the underlying mechanisms of strain-dependent neutralization sensitivity. Beyond the contribution of structural dynamics, flaviviruses exist as a structurally heterogeneous population due to an inefficient virion maturation process. Here, we investigate the interplay between virion maturation and structural dynamics that contributes to antibody-mediated neutralization. Using West Nile (WNV) and dengue (DENV) viruses produced under conditions that modify the extent of virion maturation, we investigated time-dependent changes in neutralization sensitivity associated with structural dynamics. Our results identify distinct patterns of neutralization against viruses that vary markedly with respect to the extent of virion maturation. Reducing the efficiency of virion maturation resulted in greater time-dependent changes in neutralization potency and a marked reduction in the stability of the particle at 37°C compared to more mature virus. The fact that the neutralization sensitivity of WNV and DENV did not increase after prolonged incubation in the absence of antibody, regardless of virion maturation, suggests that the dynamic processes that govern epitope accessibility on infectious viruses are reversible. Against the backdrop of heterogeneous flavivirus structures, differences in the pathways by which viruses "breathe" represent an additional layer of complexity in understanding maturation state-dependent patterns of antibody recognition. Importance: Flaviviruses exist as a group of related structures at equilibrium that arise from the dynamic motion of E proteins that comprise the antigenic surface of the mature virion. This process has been characterized for numerous viruses and is referred to as viral "breathing." Additionally, flaviviruses are structurally heterogeneous due to an inefficient maturation process responsible for cleaving prM on the virion surface. Both of these mechanisms vary the exposure of antigenic sites available for antibody binding and impact the ability of antibodies to neutralize infection. We demonstrate that virions with inefficient prM cleavage "breathe" differently than their more mature counterparts, resulting in distinct patterns of neutralization sensitivity. Additionally, the maturation state was found to impact virus stability in solution. Our findings provide insight into the complex flavivirus structures that contribute to infection with the potential to impact antibody recognition.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25078693      PMCID: PMC4178732          DOI: 10.1128/JVI.01140-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

Review 1.  Structural dynamics, an intrinsic property of viral capsids.

Authors:  J Witz; F Brown
Journal:  Arch Virol       Date:  2001-12       Impact factor: 2.574

2.  Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells.

Authors:  W D Crill; J T Roehrig
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Structure of dengue virus: implications for flavivirus organization, maturation, and fusion.

Authors:  Richard J Kuhn; Wei Zhang; Michael G Rossmann; Sergei V Pletnev; Jeroen Corver; Edith Lenches; Christopher T Jones; Suchetana Mukhopadhyay; Paul R Chipman; Ellen G Strauss; Timothy S Baker; James H Strauss
Journal:  Cell       Date:  2002-03-08       Impact factor: 41.582

4.  Dengue virus: two hosts, two structures.

Authors:  Felix A Rey
Journal:  Nature       Date:  2013-05-23       Impact factor: 49.962

Review 5.  Degrees of maturity: the complex structure and biology of flaviviruses.

Authors:  Theodore C Pierson; Michael S Diamond
Journal:  Curr Opin Virol       Date:  2012-03-23       Impact factor: 7.090

6.  Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial.

Authors:  Arunee Sabchareon; Derek Wallace; Chukiat Sirivichayakul; Kriengsak Limkittikul; Pornthep Chanthavanich; Saravudh Suvannadabba; Vithaya Jiwariyavej; Wut Dulyachai; Krisana Pengsaa; T Anh Wartel; Annick Moureau; Melanie Saville; Alain Bouckenooghe; Simonetta Viviani; Nadia G Tornieporth; Jean Lang
Journal:  Lancet       Date:  2012-09-11       Impact factor: 79.321

7.  Mechanism and significance of cell type-dependent neutralization of flaviviruses.

Authors:  Swati Mukherjee; Kimberly A Dowd; Carolyn J Manhart; Julie E Ledgerwood; Anna P Durbin; Stephen S Whitehead; Theodore C Pierson
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

8.  Dengue structure differs at the temperatures of its human and mosquito hosts.

Authors:  Xinzheng Zhang; Ju Sheng; Pavel Plevka; Richard J Kuhn; Michael S Diamond; Michael G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-08       Impact factor: 11.205

9.  Structural basis of differential neutralization of DENV-1 genotypes by an antibody that recognizes a cryptic epitope.

Authors:  S Kyle Austin; Kimberly A Dowd; Bimmi Shrestha; Christopher A Nelson; Melissa A Edeling; Syd Johnson; Theodore C Pierson; Michael S Diamond; Daved H Fremont
Journal:  PLoS Pathog       Date:  2012-10-04       Impact factor: 6.823

10.  The global distribution and burden of dengue.

Authors:  Samir Bhatt; Peter W Gething; Oliver J Brady; Jane P Messina; Andrew W Farlow; Catherine L Moyes; John M Drake; John S Brownstein; Anne G Hoen; Osman Sankoh; Monica F Myers; Dylan B George; Thomas Jaenisch; G R William Wint; Cameron P Simmons; Thomas W Scott; Jeremy J Farrar; Simon I Hay
Journal:  Nature       Date:  2013-04-07       Impact factor: 49.962

View more
  51 in total

1.  Dengue type 1 viruses circulating in humans are highly infectious and poorly neutralized by human antibodies.

Authors:  Rajendra Raut; Kizzmekia S Corbett; Rashika N Tennekoon; Sunil Premawansa; Ananda Wijewickrama; Gayani Premawansa; Piotr Mieczkowski; Claudia Rückert; Gregory D Ebel; Aruna D De Silva; Aravinda M de Silva
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-05       Impact factor: 11.205

2.  Recovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse Virulence.

Authors:  Alexander J McAuley; Maricela Torres; Jessica A Plante; Claire Y-H Huang; Dennis A Bente; David W C Beasley
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

Review 3.  Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? The Challenges of a Dengue Vaccine.

Authors:  Gavin Screaton; Juthathip Mongkolsapaya
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-06-01       Impact factor: 10.005

Review 4.  Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity.

Authors:  Laura A VanBlargan; Leslie Goo; Theodore C Pierson
Journal:  Microbiol Mol Biol Rev       Date:  2016-10-26       Impact factor: 11.056

5.  Monoclonal Antibodies as Prophylactic and Therapeutic Agents Against Chikungunya Virus.

Authors:  April M Clayton
Journal:  J Infect Dis       Date:  2016-12-15       Impact factor: 5.226

6.  Hypervariable region 1 and N-linked glycans of hepatitis C regulate virion neutralization by modulating envelope conformations.

Authors:  Jannick Prentoe; Rodrigo Velázquez-Moctezuma; Elias H Augestad; Andrea Galli; Richard Wang; Mansun Law; Harvey Alter; Jens Bukh
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-30       Impact factor: 11.205

7.  Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice.

Authors:  Gopal Sapparapu; Estefania Fernandez; Nurgun Kose; Julie M Fox; Robin G Bombardi; Haiyan Zhao; Christopher A Nelson; Aubrey L Bryan; Trevor Barnes; Edgar Davidson; Indira U Mysorekar; Daved H Fremont; Benjamin J Doranz; Michael S Diamond; James E Crowe
Journal:  Nature       Date:  2016-11-07       Impact factor: 49.962

Review 8.  Structure-Based Vaccine Antigen Design.

Authors:  Barney S Graham; Morgan S A Gilman; Jason S McLellan
Journal:  Annu Rev Med       Date:  2019-01-27       Impact factor: 13.739

Review 9.  Shake, rattle, and roll: Impact of the dynamics of flavivirus particles on their interactions with the host.

Authors:  Richard J Kuhn; Kimberly A Dowd; Carol Beth Post; Theodore C Pierson
Journal:  Virology       Date:  2015-03-30       Impact factor: 3.616

10.  Characterization of a potent and highly unusual minimally enhancing antibody directed against dengue virus.

Authors:  Max Renner; Aleksandra Flanagan; Wanwisa Dejnirattisai; Chunya Puttikhunt; Watchara Kasinrerk; Piyada Supasa; Wiyada Wongwiwat; Kriangkrai Chawansuntati; Thaneeya Duangchinda; Alison Cowper; Claire M Midgley; Prida Malasit; Juha T Huiskonen; Juthathip Mongkolsapaya; Gavin R Screaton; Jonathan M Grimes
Journal:  Nat Immunol       Date:  2018-10-15       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.